Client Login
  • Who We Are
  • Why Us
  • Where We Excel
    • Education & Not-for-Profit
    • Life Sciences & Healthcare
    • Technology
  • News
    • Education & Not-for-Profit
    • Life Sciences & Healthcare
    • Technology
  • Insights
    • Education & Not-for-Profit
    • Life Sciences & Healthcare
    • Technology
  • Contact Us
Client Login
  • Who We Are
  • Why Us
  • Where We Excel
    • Education & Not-for-Profit
    • Life Sciences & Healthcare
    • Technology
  • News
    • Education & Not-for-Profit
    • Life Sciences & Healthcare
    • Technology
  • Insights
    • Education & Not-for-Profit
    • Life Sciences & Healthcare
    • Technology
  • Contact Us

Park Square Executive Search

  • Edit this post
  • All Posts

Contributors

  • Aaron Lapat
    Managing Partner
  • Bruce Rychlik
    Managing Partner, Life Sciences
  • Erik Lundh
    Managing Partner
  • Jesse Hershman
    Partner
  • Jonathan Fortescue
    Managing Partner
  • Park Square Executive Search
  • Stacey Lerner
    Partner

Park Square Executive Search Archive

  • December 2024 (1)
  • November 2024 (3)
  • October 2024 (3)
  • September 2024 (5)
  • August 2024 (3)
  • July 2024 (5)
  • June 2024 (3)
  • May 2024 (5)
  • April 2024 (4)
  • February 2024 (6)
  • January 2024 (4)
  • December 2023 (1)
  • November 2023 (4)
  • October 2023 (3)
  • September 2023 (8)
  • August 2023 (2)
  • July 2023 (1)
  • June 2023 (5)
  • May 2023 (6)
  • April 2023 (2)
  • March 2023 (4)
  • February 2023 (2)
  • January 2023 (2)
  • December 2022 (1)
  • November 2022 (6)
  • October 2022 (3)
  • September 2022 (6)
  • August 2022 (6)
  • June 2022 (5)
  • May 2022 (5)
  • April 2022 (3)
  • March 2022 (8)
  • February 2022 (3)
  • January 2022 (11)
  • December 2021 (5)
  • November 2021 (5)
  • October 2021 (8)
  • September 2021 (4)
  • July 2021 (5)
  • June 2021 (6)
  • May 2021 (9)
  • April 2021 (4)
  • March 2021 (4)
  • February 2021 (2)
  • January 2021 (9)
  • December 2020 (1)
  • November 2020 (3)
  • October 2020 (2)
  • September 2020 (2)
  • August 2020 (2)
  • July 2020 (6)
  • June 2020 (4)
  • May 2020 (5)
  • April 2020 (8)
  • March 2020 (4)
  • February 2020 (1)
  • January 2020 (5)
  • December 2019 (3)
  • November 2019 (3)
  • October 2019 (2)
  • September 2019 (3)
  • August 2019 (3)
  • July 2019 (3)
  • June 2019 (5)
  • May 2019 (6)
  • April 2019 (7)
  • March 2019 (9)
  • February 2019 (5)
  • January 2019 (1)
  • December 2018 (3)
  • November 2018 (2)
  • October 2018 (4)
  • September 2018 (5)
  • August 2018 (5)
  • July 2018 (3)
  • June 2018 (2)
  • May 2018 (6)
  • April 2018 (4)
  • March 2018 (11)
  • February 2018 (2)
  • December 2017 (2)
  • November 2017 (6)
  • October 2017 (5)
  • September 2017 (3)
  • August 2017 (5)
  • July 2017 (7)
  • June 2017 (6)
  • May 2017 (11)
  • April 2017 (13)
  • March 2017 (30)
  • February 2017 (4)
  • January 2017 (3)
  • December 2016 (2)
  • November 2016 (2)
  • October 2016 (1)
  • September 2016 (1)
  • June 2016 (2)
  • May 2016 (2)
  • April 2016 (2)
  • March 2016 (5)
  • February 2016 (3)
  • January 2016 (2)
  • December 2015 (4)
  • November 2015 (3)
  • October 2015 (3)
  • September 2015 (2)
  • August 2015 (1)
  • July 2015 (4)
  • June 2015 (4)
  • May 2015 (3)
  • April 2015 (2)
  • March 2015 (5)
  • February 2015 (4)
  • January 2015 (6)
  • December 2014 (8)
  • November 2014 (4)
  • October 2014 (4)
  • September 2014 (2)
  • August 2014 (3)
  • July 2014 (7)
  • June 2014 (2)
  • May 2014 (4)
  • April 2014 (4)
  • March 2014 (4)
  • February 2014 (1)
  • January 2014 (7)
  • December 2013 (1)
  • October 2013 (2)
  • September 2013 (1)
  • July 2013 (4)
  • June 2013 (1)
  • May 2013 (7)
  • April 2013 (6)
  • March 2013 (4)
  • February 2013 (5)
  • January 2013 (5)

0 0

ALZHEIMER’S DRUG DEVELOPMENT COMPANY COGNITION THERAPEUTICS APPOINTS KENNETH I. MOCH PRESIDENT & CEO

Park Square Executive Search
October 28, 2016
https://www.passle.net/Content/Images/passle_logo-186px.png Passle https://passle.net
Post contributor:Park Square Executive Search, Park Square
Park Square Executive Search
  •  executive search
  •  news
  •  life sciences

Cognition Therapeutics, Inc., a clinical stage neuroscience therapeutics company, announced today that Kenneth I. Moch has been appointed President and Chief Executive Officer of the company. Mr. Moch will also join the company’s Board of Directors.

http://cogrx.com/2016/10/28/alzheimers-drug-development-company-cognition-therapeutics-appoints-kenneth-i-moch-president-ceo/

featured image unknownx500
More posts by Park Square Executive Search
Park Square Places Aldor Delp as Chief Executive Officer at ResNav Solutions
Park Square Places Aldor Delp as Chief Executive Officer at ResNav Solutions
Park Square Executive Search
Park Square Places Jamie Lewis as Chief Commercial Officer at Inflammatix
Park Square Places Jamie Lewis as Chief Commercial Officer at Inflammatix
Park Square Executive Search
Rubedo Life Sciences Appoints Former Allergan Executive and Biotechnology Veteran Dr. Frederick Beddingfield III as CEO
Rubedo Life Sciences Appoints Former Allergan Executive and Biotechnology Veteran Dr. Frederick Beddingfield III as CEO
Park Square Executive Search
Park Square Places Nelson Azoulay as Senior Vice President of Strategy and Business Development at Flagship Pioneering
Park Square Places Nelson Azoulay as Senior Vice President of Strategy and Business Development at Flagship Pioneering
Park Square Executive Search
Executive Turnover Analysis - PE-backed SaaS
Executive Turnover Analysis - PE-backed SaaS
Park Square Executive Search
Recent posts from Park Square Executive Search
Life Sciences Quarterly Newsletter from Park Square Executive Search
Life Sciences Quarterly Newsletter from Park Square Executive Search
Erik Lundh
Time to update the list...
Time to update the list...
Aaron Lapat
Deep Genomics Announces the Appointment of Brian O'Callaghan as CEO
Deep Genomics Announces the Appointment of Brian O'Callaghan as CEO
Erik Lundh
Dr. Laura Carter joins Character Biosciences as CSO
Dr. Laura Carter joins Character Biosciences as CSO
Erik Lundh
Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions
Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions
Erik Lundh
 repost  cancel

As a free user, you can like posts.

To repost this post to your own Passle blog, you will need to upgrade your account.

For plans and pricing, please contact our sales team at sales@passle.net

Sorry, you don't have permission to repost or create posts.

 cancel

Repost successful!

View the repost

Something went wrong whilst reposting - please try again.

Sorry - this is not an option. This post already exists in the Passle you have selected.

Try reposting to another Passle.

  • Boston
    125 Summer Street, 18th Floor
    Boston, MA 02110
    617-401-2990
  • Menlo Park
    325 Sharon Park Drive
    Menlo Park, CA 94025
    650-308-8140
  • San Diego
    3525 Del Mar Heights Road
    San Diego, CA 92130
    858-314-9646
  • Follow Us
Copyright © 2018 Park Square Executive Search.
Website Design by Jackrabbit
Website Design by Jackrabbit